LUPIN 27 OCT FUT
1,955.20+5.40(+0.28%)
19-Oct-2610:28:19 PM
Underlying
Lupin Limited
Option Chain1,951.700.00(0.00)
Day’s Open
NA
Prev. Day’s Close
1,949.80
Average traded price
NA
Spot Price (Vs Prem/Disc)
1,951.70 (
NA
)Volume
NA
OI in Lacs (Chg%)
76.20 (-9.19%)
Market Lot
425
Price OI Analysis
Short Covering
Rollover / Cost(Cost%)
3.75 / 19.80(1.01%)
Market Wide Position Limit
NA
19 Oct 2026 10:28:19 PM
Futures Spot Comparative
Oct
Premium on spot
+0.18%
LTP
1,955.20
Nov
Premium on spot
+1.19%
LTP
1,975.00
Dec
Premium on spot
+1.96%
LTP
1,990.00
News/ CorporateEvents
Live News
08 Oct 09:00 PM
Lupin Limited : Lupin: Company Gets US FDA Nod for Phytonadione Injectable Emulsion 1 MG/0.5 ML Pre-filled Syringe.
Equity
06 Oct 09:48 AM
Lupin Limited : Lupin: Launches Formoflo-g MDI, World’s First Fixed-dose Triple Combination Drug For COPD Management
Equity
30 Sep 09:07 AM
Lupin Limited : Update On Pharma Co's: Sc Seeks Uniform 16% Retail Markup Cap On Medicines, Flags Wide MRP-PTR Gap - Newspaper
Equity
28 Sep 09:20 AM
Lupin Limited : Lupin: Co. Receives Tentative Approval From U.s. FDA For Novel Apixaban Oral Suspension
Equity
17 Sep 08:56 AM
Nomura on Lupin Maintains Buy with Target Price of ₹2,675 as management targets one-third of revenue from innovation/specialty business, expects 20-30% India growth ahead of the broader market, may pursue acquisitions up to $2bn, sees a short-lived U.S. trough, double-digit Europe/emerging-market growth and long-term CDMO scale-up.
Equity
Technicals of Underlying
19-Oct-2026
Something went wrong! Please try after sometime.
Something went wrong! Please try after sometime.
Something went wrong! Please try after sometime.
Peer Comparison
LUPIN 27 OCT FUT vs Peers
SUNPHARMA 27 OCT FUT
1801.00+44.50(+2.53%)
LAURUSLABS 27 OCT FUT
2037.70+29.50(+1.47%)
ZYDUSLIFE 27 OCT FUT
1141.00+21.40(+1.91%)
CIPLA 27 OCT FUT
1322.70-1.80(-0.14%)
DRREDDY 27 OCT FUT
1221.40+44.80(+3.81%)